AzurRx BioPharma, Inc. | Business Finance | Business Contracts

Form of Registration Rights Agreement (Filed With SEC on July 18, 2022)

Form of Purchase Agreement (Filed With SEC on July 18, 2022)

Form of Placement Agent Warrant (Filed With SEC on July 18, 2022)

Form of Waiver Agreement (Filed With SEC on May 13, 2022)

Description of Capital Stock (Filed With SEC on March 31, 2022)

Senior Convertible Note A, dated February 14, 2019 (Filed With SEC on February 20, 2019)

Form of Pledge Agreement, dated February 14, 2019 (Filed With SEC on February 20, 2019)

Form of Warrant (Filed With SEC on July 18, 2022)

Form of Purchase Agreement (Filed With SEC on March 1, 2022)

Form of Warrant Amendment Agreement (Filed With SEC on March 1, 2022)

Form of Placement Agent Warrant (Filed With SEC on March 1, 2022)

Form of Series C Warrant (Filed With SEC on March 1, 2022)

Form of Pre-Funded Warrant (Filed With SEC on March 1, 2022)

Form of Waiver (Filed With SEC on February 7, 2022)

Form of Wainwright Warrant (Filed With SEC on July 27, 2021)

Form of Wainwright Warrant (Filed With SEC on March 10, 2021)

Form of Warrant (Filed With SEC on March 10, 2021)

Form of Wainwright Warrant (Filed With SEC on January 8, 2021)

Form of Wainwright Warrant (Filed With SEC on July 22, 2019)

Underwriting Agreement, dated July 17, 2019 (Filed With SEC on July 22, 2019)

Form of Selling Agent Warrant (Filed With SEC on May 14, 2019)

Form of Selling Agent Warrant (Filed With SEC on April 3, 2019)

Registration Rights Agreement, dated February 14, 2019 (Filed With SEC on February 20, 2019)

Warrant Amendment Agreement, dated February 14, 2019 (Filed With SEC on February 20, 2019)

Senior Convertible Note B, dated February 14, 2019 (Filed With SEC on February 20, 2019)

Note Purchase Agreement, dated February 14, 2019 (Filed With SEC on February 20, 2019)

AzurRx BioPharma, Inc. (39) | Business Finance (28)